Eight of the eleven proteins with significantly lower levels in early stage ovarian cancer were also found at reduced levels in sera from late stage HGSOC, including ITGAV [12], while three biomarkers (CPE, IFNg-R1, SEZ6L) were significantly lower only in the early stage samples. Here, SEZ6L is linked to ovarian cancer.